Welcome to our dedicated page for Scholar Rock Holding SEC filings (Ticker: SRRK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scholar Rock Holding Corporation filings document the public-company record of a Nasdaq-listed biopharmaceutical issuer focused on apitegromab, spinal muscular atrophy, and myostatin biology programs. Current reports on Form 8-K cover operating and financial results, Regulation FD business updates, apitegromab regulatory disclosures, preliminary cash updates, and amendments correcting furnished earnings materials.
The company’s SEC record also includes proxy materials for director elections, auditor ratification, and advisory executive-compensation votes. Capital-structure disclosures identify SRRK common stock listed on the Nasdaq Global Select Market and include shelf registration and at-the-market offering materials for common stock sales.
FLIER JEFFREY S. reported acquisition or exercise transactions in this Form 4 filing.
Scholar Rock Holding Corp director Jeffrey S. Flier received new equity awards as part of his compensation. He was granted 6,839 restricted stock units, each representing one share of common stock upon vesting, and 4,310 stock options to buy common stock at $45.33 per share.
The RSUs vest on the earlier of June 15, 2027 or the company’s next Annual Meeting, as long as he continues to serve the company. The options vest and become fully exercisable on the earlier of the first anniversary of the grant date or the next Annual Meeting, also subject to continued service. After the RSU grant, his direct common stock position is 30,909 shares, including 24,070 shares of common stock and 6,839 RSUs.
Scholar Rock Holding Corp director Joshua Reed received equity compensation in the form of restricted stock units and stock options. He was granted 6,839 RSUs, each representing one share of common stock upon vesting, which occurs on the earlier of June 15, 2027 or the company’s next annual meeting, subject to continued service. He also received options for 4,310 shares of common stock at an exercise price of $45.33 per share, vesting on the earlier of the first anniversary of the grant date or the next annual meeting, again subject to continued service. Following these awards, Reed directly holds or has rights to 22,571 common shares and RSUs in total, plus 4,310 stock options, indicating a routine, compensation-related increase in his equity stake rather than any open-market buying or selling.
Scholar Rock Holding Corp director Richard Brudnick received equity compensation awards rather than buying shares on the market. He was granted 6,839 restricted stock units, each representing one share of common stock that will vest on the earlier of June 15, 2027 or the company’s next Annual Meeting, subject to continued service. Following this grant, he holds 21,896 common-share interests, including these RSUs. He was also granted stock options for 4,310 shares of common stock at an exercise price of $45.33 per share, which will vest and become fully exercisable on the earlier of the first anniversary of the grant date or the next Annual Meeting, again contingent on continued service.
Scholar Rock Holding Corp director Kristina Burow reported new equity awards and updated her holdings. She received 6,839 restricted stock units, each representing one common share upon vesting, bringing her direct holdings to 110,871 common shares plus 6,839 RSUs. She also received an option grant for 4,310 shares of common stock at an exercise price of $45.33 per share, expiring on June 4, 2036, which will vest on the earlier of the first anniversary of grant or the company’s next annual meeting, subject to continued service. Separately, 2,345,711 common shares are reported as indirectly held by ARCH Venture Fund VIII, L.P. and related entities, over which she has no voting or investment control and for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Gilman Michael reported acquisition or exercise transactions in this Form 4 filing.
Scholar Rock Holding Corp director Michael Gilman received new equity awards. He was granted 6,839 restricted stock units, each representing one future common share, vesting on the earlier of June 15, 2027 or the next Annual Meeting, subject to continued service. He also received options to buy 4,310 shares at $45.33 per share, expiring in 2036, which vest on the earlier of one year from grant or the next Annual Meeting. Following these awards, his direct holdings total 62,055 common shares, including 55,216 shares and 6,839 RSUs, plus 4,310 stock options.
Director Katie Peng received new equity awards from Scholar Rock Holding Corp6,839 restricted stock units (RSUs), each representing one future share of common stock. These RSUs vest on the earlier of June 15, 2027 or the company’s next Annual Meeting, subject to continued service.
Peng was also granted 4,310 stock options to buy common stock at an exercise price of $45.33 per share, expiring on June 4, 2036. The options vest and become fully exercisable on the earlier of the first anniversary of the grant date or the next Annual Meeting, again subject to continued service. After these grants, she holds 39,747 shares/RSUs-equivalent in total, consisting of 26,201 common shares and 13,546 RSUs, plus 4,310 stock options.
Scholar Rock Holding Corp director Srinivas Akkaraju received new equity awards. He was granted 6,839 restricted stock units, each representing one future share of common stock upon vesting, and now directly holds 27,971 common shares including these RSUs and 21,132 already‑held shares.
He was also granted options for 4,310 shares of common stock at an exercise price of $45.33 per share, expiring on June 4, 2036. The RSUs vest on the earlier of June 15, 2027 or the next Annual Meeting, and the options vest on the earlier of the first anniversary of grant or the next Annual Meeting, in each case subject to continued service. Indirectly, entities he oversees hold 6,367,614 and 530,038 additional shares.
Scholar Rock Holding Corporation reported the results of its annual stockholder meeting held on June 4, 2026. Stockholders elected four Class II directors—David Hallal, Kristina Burow, Michael Gilman, Ph.D., and Katie Peng—to three-year terms ending at the 2029 annual meeting.
Support for these directors ranged from 86,753,433 to 96,269,103 votes in favor, with 14,598,794 to 24,114,464 votes withheld. Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 113,411,438 votes for, 764,548 against, and 500,031 abstentions.
In addition, stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, with 68,280,961 votes for, 42,455,921 against, and 131,015 abstentions. These outcomes confirm continued stockholder approval of the Company’s board composition, auditor selection, and executive pay program.
Scholar Rock Holding Corporation filing reports that Redmile Group, LLC and related parties hold a combined 9,066,621 shares of Common Stock, representing 7.6% of the class based on 119,103,774 shares outstanding as of March 31, 2026. The filing attributes 9,066,621 shares to Redmile and Jeremy C. Green and 6,907,180 shares to RedCo II Master Fund, L.P.
The schedule clarifies voting and dispositive power is shared for the disclosed shares because they are held by investment vehicles managed by Redmile; Redmile and Mr. Green disclaim beneficial ownership except for any pecuniary interest. The filing is an amendment to a prior Schedule 13G/A and is signed by Jeremy C. Green.
T. Rowe Price Associates, Inc. filed an amendment to a Schedule 13G disclosing 6,206,044 shares of Scholar Rock Holding Corp common stock, representing 5.4% of the class as of 03/31/2026. The filing lists 6,203,887 shares as sole voting power and 6,206,044 as sole dispositive power. The filing is signed by a Vice President on 05/15/2026.